HCSG
Healthcare Services GroupBDocument history
Earnings documents stored for HCSG.
Investor releaseQuarter not tagged2026-05-25Is Rising Analyst Optimism Redefining Healthcare Services Group’s (HCSG) Earnings Resilience Narrative?
Simply Wall St.
Is Rising Analyst Optimism Redefining Healthcare Services Group’s (HCSG) Earnings Resilience Narrative?
In recent weeks, Healthcare Services Group has seen analysts lift earnings estimates and maintain a favorable Zacks Rank #2, reflecting improved expectations for its profit outlook. This upswing in analyst confidence, marked by stronger agreement on higher EPS forecasts, underscores shifting perceptions of the company’s earnings resilience relative to its business services peers. Now we’ll examine how this refreshed analyst optimism around earnings estimates interacts with Healthcare Services Group’s existing investment narrative. Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution. To own Healthcare Services Group, you need to believe its outsourced housekeeping and dietary model can stay relevant as healthcare facilities wrestle with costs, staffing and regulation. The recent lift in earnings estimates and Zacks Rank #2 supports the near term earnings momentum as a key catalyst, but does not fundamentally change the biggest risk around client concentration and contract stability in a consolidating post-acute care industry. Among recent announcements, the Q1 2026 results stand out in light of this analyst optimism, with sales of US$462.77 million and net income of US$26.06 million. While these figures align with an improving earnings outlook, they sit alongside ongoing concerns around labor cost pressures and reimbursement-dependent customer health, which remain central to how durable any earnings improvement can be over time. Yet beneath the stronger earnings estimates, investors should be aware that concentrated exposure to financially fragile facility operators could still... Read the full narrative on Healthcare Services Group (it's free!) Healthcare Services Group's narrative projects $2.2 billion revenue and $88.9 million earnings by 2029. This requires 5.3% yearly revenue growth and a $21.0 million earnings increase from $67.9 million today. Uncover how Healthcare Services Group's forecasts yield a $26.20 fair value, a 28% upside to its current price. Simply Wall St Community members currently place Healthcare Services Group’s fair value between US$26.20 and about US$32.99 across 2 independent views, reminding you that opinions can vary widely. Set this against the recent analyst earnings upgrades and ask how client concentration and industry consolidation might influenc...
Investor releaseQuarter not tagged2026-04-24Healthcare Services Group Q1 Earnings Call Highlights
MarketBeat
Healthcare Services Group Q1 Earnings Call Highlights
Healthcare Services Group reported Q1 revenue of $462.8 million (+3.4%), net income of $26.1 million and diluted EPS of $0.37, with Environmental Services at $208.3 million (12.1% margin) and Dietary Services at $254.5 million (9% margin) and overall cost of services at 83.6% of revenue. The company outperformed its 86% cost-of-services target by about 2%, driven roughly 1% (~$4.7 million) from workers’ compensation/general liability efficiencies and lower bad debt (~$3.8 million), though management cautioned these benefits can be “lumpy.” Management is targeting mid-single-digit revenue growth for FY26 with Q2 guidance of $465–$475 million, expects H2 sequential growth, ended Q1 with $214.6 million in cash and marketable securities, an undrawn $300 million revolver extended to 2031, and returned $24 million in buybacks while announcing a $75 million repurchase program. Interested in Healthcare Services Group, Inc.? Here are five stocks we like better. Cigna Considers Humana Acquisition – What It Means for the Stocks Healthcare Services Group (NASDAQ:HCSG) reported what CEO Ted Wahl described as a “strong” start to fiscal 2026, citing growth in revenue, earnings, and cash flow as new client wins and high retention supported year-over-year gains. Chief Communications Officer Matt McKee said revenue for the first quarter totaled $462.8 million, up 3.4% from the prior year. Environmental Services revenue was $208.3 million with a segment margin of 12.1%, while Dietary Services revenue was $254.5 million with a segment margin of 9%. → Credo Stock Flashes Strong Bullish Signal—Upswing Just Starting Is Cigna Group the Nation's Best-Run Health Insurance Company? McKee said cost of services was $386.9 million, representing 83.6% of revenue. He noted the company’s goal is to manage cost of services in the 86% range, while attributing the quarter’s result to “strong service execution,” efficiencies in workers’ compensation and general liability, and lower bad debt expense. SG&A expense was $42.0 million. McKee said that after adjusting for a $1.6 million decrease in deferred compensation, SG&A was $43.6 million, or 9.4% of revenue. He said the company’s goal is to manage SG&A in a 9.5% to 10.5% range, with a longer-term goal of 8.5% to 9.5%. → Allbirds Exits Shoes, Pivots to AI With NewBird Rebrand Net income was $26.1 million, and diluted earnings per share were $0.3...
Investor releaseQuarter not tagged2026-04-23Healthcare Services Group, Inc. Q1 2026 Earnings Call Summary
Moby
Healthcare Services Group, Inc. Q1 2026 Earnings Call Summary
Revenue growth of 3.4% was primarily driven by new client acquisitions and high retention rates, supported by a robust sales pipeline across Environmental and Dietary services. Management attributes the significant margin outperformance to 'operational excellence' in the field, specifically citing improved systems adherence, regulatory compliance, and budget discipline. The industry is entering a multi-decade demographic tailwind as the first baby boomers turn 80 in 2026, which is expected to structurally increase demand for long-term and post-acute care. Workforce availability and steady occupancy rates (around 80%) are currently the primary catalysts for facility-level financial stability and service expansion. Service execution, workers' comp and general liability efficiencies, and lower bad debt expense have driven strong performance in cost of services, and the company's goal is to manage these costs in the 86% range. The company maintains a 'financial steward' role for clients, prioritizing cost mitigation through sourcing pivots if specific food or supply items face outsized price pressure. Management targets mid-single-digit revenue growth for 2026, with Q2 revenue projected between $465 million and $475 million and sequential acceleration in the second half. The long-term margin framework remains anchored at an 86% cost of services target, despite Q1 outperformance, to account for potential lumpiness in insurance and bad debt items. Strategic growth is dependent on the localized development of management candidates; field teams must prove operational proficiency before being permitted to expand their portfolios. The Dietary segment remains a primary growth lever, with only 50% penetration among existing Environmental Services clients representing significant 'low-hanging fruit' for cross-selling. Capital allocation will remain disciplined, focusing on a $75 million share repurchase program over 12 months and pursuing 'land and expand' M&A opportunities in the $20 million to $30 million range. Workers' comp and general liability efficiencies provided a $4.7 million (1%) favorable impact to cost of sales, though management cautioned this is actuarially driven and may not repeat consistently. Bad debt expense was unusually low at less than 1% of revenue due to a lack of client bankruptcies in Q1, compared to a normalized historical range of 1% to 1.5%....
Investor releaseQuarter not tagged2026-04-23Healthcare Services Group Inc (HCSG) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ...
GuruFocus.com
Healthcare Services Group Inc (HCSG) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ...
This article first appeared on GuruFocus. Revenue: $462.8 million, a 3.4% increase over the prior year. Environmental Services Revenue and Margin: $208.3 million and 12.1% margin. Dietary Services Revenue and Margin: $254.5 million and 9% margin. Cost of Services: $386.9 million or 83.6% of revenue. SG&A Expenses: $42 million; adjusted SG&A was $43.6 million or 9.4% of revenue. Net Income: $26.1 million. Diluted Earnings Per Share: $0.37 per share. Effective Tax Rate: 24.6%. Cash Flow from Operations: $43.7 million; adjusted cash flow from operations was $23.4 million. Cash and Marketable Securities: $214.6 million. Share Repurchase: $24 million of common stock repurchased in Q1. Warning! GuruFocus has detected 4 Warning Signs with HCSG. Is HCSG fairly valued? Test your thesis with our free DCF calculator. Release Date: April 22, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Healthcare Services Group Inc (NASDAQ:HCSG) reported strong first-quarter results with a 3.4% increase in revenue, reaching $462.8 million. The company achieved high retention rates and new client wins, driving year-over-year top-line growth. HCSG returned $24 million of capital through its share repurchase program, highlighting a strong balance sheet and focus on value-creating capital deployment. The company is well-positioned to benefit from demographic trends, with the aging baby boomer population expected to increase demand for long-term and post-acute care services. HCSG's liquidity position is robust, with cash and marketable securities of $214.6 million and an undrawn $300 million revolving credit facility. The company faces potential volatility in global energy and supply markets due to ongoing geopolitical conflicts, which could impact costs. While the cost of services was favorable this quarter, management cautions that benefits from workers' comp and general liability efficiencies may not be consistent in future quarters. HCSG's growth is subject to timing variability, with the start dates of new client contracts potentially impacting quarterly results. The company is still working on improving employee engagement and retention, which remains a challenge due to the decentralized nature of its workforce. Despite strong results, the company maintains a cautious outlook on cost management, aiming to keep the cost of ser...
Investor releaseQuarter not tagged2026-04-22Healthcare Services Group Tops Q1 Estimates as Shares Surge on Strong Results
InvestorsHub
Healthcare Services Group Tops Q1 Estimates as Shares Surge on Strong Results
Healthcare Services Group, Inc. (NASDAQ:HCSG) delivered a strong first-quarter performance for 2026, beating both earnings and revenue expectations and driving a sharp rally in its share price. The company reported earnings per share of $0.37, significantly above the $0.22 forecast, while revenue reached $462.8 million, modestly ahead of the $459.99 million consensus. The upbeat results prompted a more than 22% jump in premarket trading, with the stock rising to $23.69. The performance was supported by solid execution across core business lines. Environmental Services generated $208.3 million in revenue, while Dietary Services contributed $254.5 million, helping lift overall revenue by 3.4% year-on-year. Improved cost discipline and efficiency measures also supported margins, with the company outperforming its own cost management targets. Healthcare Services Group posted revenue of $462.8 million for the quarter, representing a 3.4% increase from the prior year. Earnings per share came in at $0.37, marking a substantial beat versus expectations, while net income totaled $26.1 million. Adjusted EBITDA reached $39 million, and operating cash flow stood at $43.7 million, reflecting solid underlying cash generation. Investors responded positively to the results, with the stock surging 22.43% in premarket trading and approaching recent highs. The strong reaction reflects confidence in the company’s ability to sustain earnings growth and improve profitability. Over the past year, the stock has delivered significant gains, attracting attention from value-focused investors. Looking ahead, the company expects second-quarter revenue to come in between $465 million and $475 million. For the full year, management is targeting mid-single-digit revenue growth, with performance expected to strengthen in the second half of 2026. In addition, Healthcare Services Group announced a new $75 million share repurchase program, underscoring its commitment to returning capital to shareholders and enhancing long-term value. Management highlighted continued focus on operational efficiency and disciplined capital deployment as key drivers of performance. “Our operational excellence and disciplined capital management have been key drivers of our performance this quarter,” the CEO said. The company also reiterated its focus on improving service quality, customer experience, and regulator...
Investor releaseQuarter not tagged2026-04-22Healthcare Services (HCSG) Surpasses Q1 Earnings and Revenue Estimates
Zacks
Healthcare Services (HCSG) Surpasses Q1 Earnings and Revenue Estimates
Healthcare Services (HCSG) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.23 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +68.18%. A quarter ago, it was expected that this provider of housekeeping, laundry and dietary services to health care facilities would post earnings of $0.23 per share when it actually produced earnings of $0.44, delivering a surprise of +91.3%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Healthcare Services, which belongs to the Zacks Business - Services industry, posted revenues of $462.77 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 0.06%. This compares to year-ago revenues of $447.66 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Healthcare Services shares have added about 1.2% since the beginning of the year versus the S&P 500's gain of 3.2%. While Healthcare Services has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Healthcare Services was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perfor...
TranscriptFY2026 Q12026-04-22FY2026 Q1 earnings call transcript
Earnings source - 38 paragraphs
FY2026 Q1 earnings call transcript
Thank you for standing by. My name is Rebecca, and I will be your conference operator today. At this time, I would like to welcome everyone to the HCSG 2026 First Quarter Earnings Call. [Operator Instructions] Thank you. The matters discussed on today's conference call include forward-looking statements about the business prospects of Healthcare Services Group, Inc. For Healthcare Services Group, Inc.'s most recent forward-looking statement notice, please refer to the press release issued this morning, which can be found on our website, www.hcsg.com. Actual results may differ materially from those expressed or implied as a result of various risks, uncertainties and important factors, including those discussed in the Risk Factors, MD&A and other sections of the annual report on Form 10-K and Healthcare Services Group, Inc.'s other SEC filings, and as indicated in our most recent forward-looking statements notice. Additionally, management will be discussing certain non-GAAP financial measures. A reconciliation of these items to U.S. GAAP can be found in this morning's press release. I would now like to turn the call over to Ted Wahl, CEO. Please go ahead.
Good morning, everyone, and welcome to HCSG's First Quarter 2026 Earnings Call. With me today are Matt McKee, our Chief Communications Officer; and Vikas Singh, our Chief Financial Officer. Earlier this morning, we released our fourth (sic) [ first ] quarter results and plan on filing our 10-Q by the end of the week. Today, in my opening remarks, I'll discuss our Q1 highlights, share our perspective on the general business environment and discuss our strategic priorities for Q2. Matt will then provide a more detailed discussion on our Q1 results, and then Vikas will provide an update on our liquidity position and capital allocation progression. We will then open up the call for Q&A. So with that overview, I'd like to now discuss our Q1 highlights. We delivered strong first quarter results across revenue, earnings and cash flow, and we have carried that positive momentum into the second quarter. New client wins and high retention rates drove our year-over-year top line growth and our field-based team's operational excellence led to quality service outcomes and consistent margins. We also returned $24 million of capital through our share repurchase program and ended the quarter with a strong balance sheet and ROIC profile, underscoring our focus on value-creating capital deployment. I'd like to now share our perspective on the general business environment. Industry fundamentals continue to gain strength, highlighted by the multi-decade demographic tailwind that is now beginning to work its way into the long-term and post-acute care system. In 2026, the first baby boomers will turn 80 years old. And by the year 2030, all 70 million-plus boomers will be over the age of 65, with the oldest being in their mid-80s, the primary age cohort for long-term and post-acute care utilization. We expect that the demand and opportunities for service providers in this space, especially for those with compelling value propositions, durable business models and market-leading positions to only increase in the months and years ahead. The most recent industry operating trends remain positive as well, highlighted by steady occupancy, increasing workforce availability and a stable reimbursement environment. We remain optimistic that the administration will continue to prioritize the rationalization of regulations and policy to better align with the changing and expanding needs of our nation's most vulnerable and the provider communities we service. Beyond our core industry trends, we are closely monitoring the broader macro landscape, including the volatility in global energy and supply markets resulting from ongoing geopolitical conflicts. Our role as financial stewards for our clients remains a nonnegotiable priority and serves as our North Star as we navigate this environment. To that end, while we have not observed direct on-invoice impact from these global events, our purchasing and procurement teams are actively monitoring the landscape and surveying our supply chain to stay ahead of any developing trends. Fundamental to these efforts is the depth of our long-standing vendor partnerships, which provide critical visibility and stability necessary to navigate market volatility with confidence. In the event that specific supplies or food items experience outsized inflationary or cost pressure, we are prepared to pivot our sourcing strategies to mitigate direct exposure. Ultimately, the rigorous work we have done to enhance our contractual frameworks allows us to pass through unavoidable cost increases, ensuring we preserve our margins while continuing to deliver market-leading service. Looking ahead to Q2, our top 3 strategic priorities remain driving growth by developing management candidates, converting sales pipeline opportunities and retaining our existing facility business. Managing cost through field-based operational execution and prudent spend management at the enterprise level and optimizing cash flow with increased customer payment frequency, enhanced contract terms and disciplined working capital management. We are confident that continuing to execute on our strategic priorities, supported by our robust business fundamentals will enable us to drive growth while delivering sustainable, profitable results. So with those introductory comments, I'll turn the call over to Matt.
Thanks, Ted, and good morning, everyone. Revenue was reported at $462.8 million, a 3.4% increase over the prior year. Segment revenues and margins for Environmental Services were reported at $208.3 million and 12.1%. Segment revenues and margins for dietary services were reported at $254.5 million and 9%. Our 2026 growth plans are oriented around mid-single-digit revenue growth with Q2 revenue in the $465 million to $475 million range and sequential revenue growth in the second half of the year compared to the first half of the year. Cost of services was reported at $386.9 million or 83.6%. Cost of services benefited from strong service execution, workers' comp and general liability efficiencies and lower bad debt expense. Our goal is to manage cost of services in the 86% range. SG&A was reported at $42 million. After adjusting for the $1.6 million decrease in deferred compensation, SG&A was $43.6 million or 9.4%. Our goal is to manage SG&A in the 9.5% to 10.5% range based on investments that we've made and spoken about in previous quarters with the longer-term goal of managing those costs into the 8.5% to 9.5% range. Our effective tax rate was reported at 24.6%. We expect our 2026 effective tax rate to be approximately 25%. Net income and diluted earnings per share were reported at $26.1 million and $0.37 per share. I'd now like to turn the call over to Vikas.
Thank you, Matt, and good morning, everyone. Starting with our liquidity and cash flows. Our primary sources of liquidity are cash flow from operating activities, cash and cash equivalents and our revolving credit facility. Cash flow from operations was reported at $43.7 million. After adjusting for the $20.3 million increase in the payroll accrual, cash flow from operations was $23.4 million. We wrapped up the first quarter with cash and marketable securities of $214.6 million, and our credit facility of $300 million was undrawn with utilization limited to LCs only. On April 7, we amended our existing credit agreement to extend the maturity of our $300 million revolving credit facility to 2031. In tandem, the SOFR-based pricing grid has been favorably modified and covenant flexibility has been enhanced. Our capital allocation plans remain unchanged from what we outlined last year, and we are on track to execute. Our capital allocation across organic growth, M&A and share repurchases continues to be grounded in discipline and consistency. Our enhanced liquidity provides us the flexibility to pursue all of these priorities without trade-offs. In February 2026, we announced plans to further accelerate the pace of our share buybacks and repurchase $75 million of our common stock over 12 months. In the first quarter, we repurchased $24 million of our common stock. We now have 9.2 million shares remaining under our current share repurchase authorization. With that, we will conclude our opening remarks and open up the call for Q&A.
[Operator Instructions] And your first question comes from the line of Ryan Daniels with William Blair.
This is Matthew Mardula on for Ryan. So in your prepared remarks, you touched up on this, but I want to dive deeper into it. So we saw strong results in cost of services as a percentage of revenue being at 83.6% this quarter, better than the guidance. Was there any one-time benefits this quarter? And what exactly drove that strong performance in the first quarter? Also, as we look for the rest of the year, with you reiterating the 86% cost of services as a percentage of revenue, how should we think about the rest of the quarter given the strong Q1 performance?
Matt, this is Matt McKee. As we've previously discussed, the primary driver of managing cost of services within that targeted range and overall margin consistency for us is really service execution. And the recent positive service execution trends in customer experience, systems adherence, regulatory compliance and budget discipline, all of which are near-term margin drivers carried over into Q1. And the expectation is that, that carries forward throughout 2026 as well. So that's why we remain confident in our ability to continue to manage costs in that 86% range. And it's worth noting, Matt, that service execution is not something that happens on autopilot, right? There are no elements of it that are given. Our field-based management teams are working very diligently to deliver on our expectations, and they deserve a lot of credit for that execution. So that said, there are always going to be some movement month-to-month, quarter-to-quarter and the timing of certain items can have a positive impact, and that was the case in Q1 results as well in that work comp and general liability efficiencies continue to be driven by our focus and commitment to training and safety protocol that we've implemented in the facilities and lower bad debt expense. That's been favorably impacted by our strong cash collection efforts and the scarcity of bankruptcies or reorgs during Q1.
Yes. And Matt, this is Vikas. If you want to unpack the outperformance in different buckets, what we would say is, look, we've outperformed the 86% by, call it, 2%. Out of that, 1% is coming from workers' comp and general liability. Those efficiencies contributed about $4.7 million to the favorable cost of sales outcome for the quarter. Now while that reflects the ongoing efforts that Matt just talked about, what I would remind you is that this impact can be lumpy. And the fact that we got that number in one quarter may not necessarily lead to similar benefits in subsequent quarters because that benefit is based on the frequency and the size of claims. It's based on the insurance and actuarial model. And while it's indicative of how we've been performing, it does not guarantee similar repeat performances in subsequent quarters. So that's about 1% of that 2% outperformance. I would say the remaining outperformance this quarter, as Matt has already alluded to, came from bad debt and service execution. On the bad debt front, you'll see this number in the Q that we'll file later this week, but that number for the quarter is $3.8 million. That's less than 1% of revenue. If you look at where we've been in the recent past, we've been at 2% plus. If you look at a more normalized historical average, we are between 1% to 1.5%. So it's really those two factors plus the operational excellence that's driving the number this quarter. But that said, we still feel that 86% is the right way to go because these events, while favorable, can be lumpy and are not guaranteed to be repeated in subsequent quarters, although we'll try our best to do what we can. But I think it takes us back to 86% being the goal and the target for us.
Great. That's extremely helpful. Now how has the development of managerial candidates trended recently? And with the continued addition of new clients this quarter and with expectations of that continuing in the upcoming quarters, how are you planning to be able to keep pace with having enough managerial candidates? And I know it probably varies by region, but any updates on growth and I'm ensuring you have enough manager candidates would be great to hear about.
Yes, that's exactly right, Matt. The benefit that we have is that our expectations relative to management development are all grounded in the localized efforts within not only our regions, but more specifically down to the district level, where we have our 12 facility districts and the expectation is that each district will be executing their own management development efforts through their certified training facilities. So the expectation is that the recruiting efforts, the hiring, the training, the development, ultimately, the retention and placement of those management candidates is very much an exercise that's executed within that district structure. So it's very much those bottoms-up ground-up efforts that aggregate to total company top line growth opportunities. And it is that marriage of management development with business development, but again, executed locally that when it's rolled up and executed properly, yields that mid-single-digit growth for the company. Correctly noted as well, Matt, in the way that you asked the question is that, of course, there are regional variabilities, whether that's a market dynamic or it's simply a management issue. Some folks are further ahead of that curve. Others will struggle because, of course, we don't compromise our standards relative to service execution and performance per our previous comments relative to cost of services if there is a local team that's not executing on client satisfaction, delivering that customer experience, adhering to our operational systems, delivering regulatory compliance and, of course, executing with budget discipline as stewards -- financial stewards for our clients, we won't let them grow the business in their area. They have to demonstrate that they're capable of appropriately managing their business in their current portfolio before we'll allow them to grow. So there will always be problem children, and that's the beauty of having invested in that middle management structure is that, number one, we can quickly identify areas of concern and some folks who may need extra attention and then quickly be able to insert those management resources, appropriately reskill, train, develop those managers such that they can get back on track and then reengage into that critical focus for us, which would be management development, very much tied to business development efforts. But when you roll it all up when we look at that landscape right now, Matt, we're very pleased with where we are, and we don't have any limitations or obstacles relative to achieving total company growth objectives in light of the strong environment relative to management development.
Your next question comes from the line of A.J. Rice with UBS.
This is James on for A.J. First of all, congrats on the strong start to the year. Could you potentially give us an update on how the campus segment did in terms of year-over-year growth? And then I think you've also expressed interest around potentially exploring more M&A opportunities, particularly potentially in campus. And maybe just an update on the capital deployment as it relates to M&A.
Yes. James, as we discussed last quarter, the campus business represents over $100 million of annualized revenue in 2025 and still a relatively small base at less than 10% of total company revenues, but we do see continued growth of that base. We're not going to report or call out specific growth in that segment at this point. But we've mentioned the synergies that exist between the environmental offering or the brand that we're executing for environmental services and our dining brand and those offerings. So as we sit here, if you think about the academic calendar, as many, if not most, of our campus clients right now are schools, we're in the selling season, right, as administrators begin to plot out their plans for the end of this academic year, the summer and then thinking ahead to next year's academic year. So from a business development and a pipeline development perspective, those folks are very much in the thick of orienting towards growth objectives from an organic perspective. And perhaps Vikas would make a comment or two just as far as how the inorganic opportunities could potentially supplement that in the campus opportunity.
Yes. And as we've talked about, we remain focused on building that M&A pipeline. We continue to evaluate incremental opportunities every quarter. And as I said earlier, our approach will continue to be grounded in discipline and consistency. And we are looking for deals that will be small, $20 million, $25 million, $30 million of purchase price such that while they look and feel like inorganic growth on day 1, they serve as an organic growth platform on day 2, so more of a land and expand. So we are busy looking at opportunities and evaluating the right fit that we will move forward with over the course of the year, but that continues to be an ongoing focus area for us.
Got it. Appreciate the color there. Maybe just one more on adjusted EBITDA, it was a really strong quarter at almost $39 million. I know you don't guide to that, and I appreciate some of the comments around the benefits you saw the cost of services this quarter. But is there any directional color you can give us with the starting point of $39 million just on seasonality considerations or how to consider or view that from a quarter-to-quarter basis from here?
Yes. You're right. Look, we've not been getting into projecting out EBITDA. But as we've mentioned in the past, the model remains very consistent and in some ways, easy to understand, which is, from our perspective, 86% cost of sales, SG&A short-term target of 9.5% to 10.5%, so call it 10% at the midpoint. And we've got a 25% tax rate, right? That puts you in the ZIP code of 4% pretax income. Our stock-based compensation and D&A typically runs at about 1.5%. I think that's the best we can do in terms of providing you a sense of where it will be. Now this quarter, EBITDA was strong, as we talked about. The results, cost of sales came out more favorable than the 86%. SG&A came out more favorable than the 10%. That said, that's not what we are projecting as the overall year outcome. So I'll let you project out EBITDA within those metrics, and there will be quarters where we do better than those and maybe not. But I think if you look at how we look at the business on an annual or a 3- to 5-year growth trajectory basis, those are the metrics that we are holding ourselves accountable to.
Your next question comes from the line of Sean Dodge with BMO Capital Markets.
Maybe just going back to the cost of services, Vikas, you mentioned the benefits in the quarter from workers' comp, general liability, bad debt. I know you've also been working on some initiatives aimed at improving engagement with employees at the hourly level and using that to improve retention and lower turnover. Maybe if you could just share some more on what specifically you're doing there? And then any impact you've seen from that yet on margins and maybe how much runway is left from initiatives like that, that have a little bit more kind of durability over the long term?
Yes. Sean, I would say, without a doubt, that continues to be an area of focus for us engaging with our employees at every level within the organization, right? It's a newer area of focus for us to identify with and engage with our line staff employees who historically, we would have thought associated more with the facility rather than with Healthcare Services Group. But as we've formalized and really kind of adopted as a North Star, our company's purpose, our vision and our values in order for us to achieve all of those, we have to have high levels of buy-in and engagement with the employees throughout the continuum. And as you can imagine, being a service-based sort of decentralized organization with the bulk of our employees executing those line staff level positions such as housekeepers and pot washers and dishwashers, food service employees, it is rather challenging to communicate with them. They're not users of e-mail, and we have limited opportunities to connect with them. So we have really explored and identified creative ways to connect with them via company intranet, establishing a proprietary app technology through which we can communicate with folks leveraging our time clocks to be able to push messages to our employees and to better understand where they are in their company experience and journey such that we can really connect with them and drive improved connectivity and outcomes. So qualitatively, without a doubt, we are seeing improved connectivity, higher levels of employee satisfaction. And from a quantitative perspective, Sean, harder to pinpoint it running through cost of services explicitly. But without a doubt, we are seeing improvement in employee retention as a result of those levels of engagement and ultimately satisfaction. So obviously, that yields greater operational outcomes by way of the customer experience, having longer-term employees in the facility. It reduces the management's requirement to be out there conducting interviews and trying to hire and replace employees who are turning over. So there's a cascade of benefits that come from that, some of which are qualitative, but without a doubt, quantitatively yielding improved employee retention data.
Okay. Great. And then on the revenue outlook, your guidance for the first half of the year implies kind of low single-digit year-on-year growth. I guess the mid-singles for the full year means you got to do something kind of like high singles year-over-year for the back half. Just anything on what's driving that? Is it just simply implementing more facilities over the year and those kind of ramping? And then just any more color on how much is coming from new clients on the housekeeping side versus dining cross-sells?
Thank you for the question, Sean. Look, I would start with the fact that the demand for our services is stronger than it's ever been. You look at our pipeline, it's robust. It's growing in terms of new business opportunities, each of which are at various stages of development, but we have a highly managed sales -- highly managed and structured sales process from the beginning stages of cultivation all the way through closing. So I think that bodes well for future, not just over the next 6 to 12 months, but beyond. And we continue in the current year to successfully execute on the organic growth strategy by developing management candidates, as Matt highlighted, that fund new business opportunities, all while retaining our base business. To the question you asked, the key drivers for us in delivering mid-single-digit growth at either the higher end of the range like we saw in 2025 or even the lower end of the range like we saw this past quarter is timing. It's the timing of HCSG management capacity and the timing of client start date preference. And I know we've talked about this before, but timing can be fluid quarter-to-quarter, knowing there's always going to be a subset of intra-quarter opportunities that may be pushed out or pulled forward depending on those two key drivers. And to help put that dynamic in perspective or context, the difference between us starting a new opportunity on April 1 as opposed to September 1 is insignificant in the context of the 3- to 5-year growth outlook we put forth, but could be impactful in a given quarter or even in a year depending on the size and scale of the opportunity. So again, our 2026 growth outlook is a range that's based on annual growth expectations, whereas the quarter-to-quarter estimates are really intended to provide additional near-term visibility. In terms of the segment breakdown, our new business pipeline is split fairly evenly between EVS and dietary, although from a revenue contribution perspective, a dietary account is typically 2x or so of that of an EVS account on a same-store basis. So as we're onboarding a comparable number of facilities, dietary and EVS revenue will increase proportionately. And just as a reminder for you and for the group, we're still 50% or so penetrated in dietary services. So you have the remainder of that to pursue relative to our EVS customer base. So that cross-selling of dietary to our existing EVS customer base remains that ultimate low-hanging fruit.
Okay. And then just last on Genesis. Any updates you can share there? Are you still providing services to them? And then just any better visibility you have at this point into where those facilities end up kind of from an operator standpoint?
Yes, continuing to provide services to the Genesis facilities without operational or payment disruption. And we continue to expect that to be the case throughout the duration of the post-petition period. In terms of updates, in January, the bankruptcy court did approve the sale of Genesis to 101 West State Street, which is a group of well-organized, well-known operators in the space who we have a relationship with. From a timing perspective, those revised bid procedures from the second auction called for a late April financing commitment letter. So that process is unfolding as we speak. And then an early summer close, although from a practical standpoint, I think there's a strong belief that, that will likely be pushed out. I know there's an option at either the buyer or the seller, purchaser or the debtor to exercise that option. So we're likely looking at a closing date later in the summer, assuming 101 West State Street can provide that financing commitment. But again, in the meantime, our priority is providing the high-quality services to Genesis, and we don't expect any disruption in operations or payment between now and the sale date.
Your next question comes from the line of Ryan Halsted with RBC Capital Markets.
I guess I know you mentioned that the industry fundamentals remain strong. But I was curious if you had seen any shift or any change in the occupancy trends with your SNF customers, especially those with kind of the shorter stay Medicare residents starting in 2026. And I think just the basis of my question is one of the large managed care companies talked about increasing their clinical reviews on SNF admissions. So I was just wondering if you had any comments or visibility on kind of those trends.
Ryan, look, overall, and I mentioned it in my opening remarks, the industry fundamentals continue to gain strength and that demographic tailwind really is beginning, at least the early stages of it are working its way into the long-term and post-acute care system. So that fundamentally is a huge positive for today and for the next few decades. It's really that continued interplay that we see at the local level between staffing availability and occupancy that remains the key for any facility success. I think more than any other factor, labor availability is the key to occupancy growth and occupancy growth is the key to consistent financial outcomes. And the most recent occupancy data are positive. They continue to be in and around 80%. And what we're seeing, to your question, is really steady across not just geographies, urban, suburban, rural, but also facility types and population, long-term short stay, et cetera. So from our perspective, we haven't relative to occupancy, seen anything other than stability and generally speaking, upward trend.
Got it. That's helpful. And then you made comments about strong momentum carrying over into Q2. And looking at your guidance for the quarter, the midpoint to the low end are for low single-digit growth. Can you maybe just help to square those comments in terms of what is the momentum you're seeing and maybe how that could be swing factors into your guide?
Yes. And look, from a momentum perspective, the most significant indicator we look at is pipeline and then obviously assessing the various stages of development of that pipeline. And our pipeline continues to grow. It continues to be robust, meaning strength across all different segments and business lines, inclusive of the campus division. And that's a real positive. And so we feel good about not just the next 6 months, but the next 3 to 5 years. From a variability perspective quarter-to-quarter, I touched on this earlier, Ryan, but it's really the timing. And it's difficult to be able to pinpoint with precision what a specific quarter will look like, not because we don't have fantastic visibility into the pipeline and the stages of development, but because it's that timing of HCSG management capacity and the timing of client start date, which can be fluid up until a scheduled or originally scheduled start date. So that is -- that's always been the case. That's not a new dynamic for HCSG or the industry for that matter. But we have an organization that's built to be highly nimble, to be able to react when we need to, be able to be proactive when we need to in those situations. So it really does come down to timing in terms of what puts us at the higher end or the lower end of that mid-single-digit range in any given quarter or in any given year.
Got it. That's very clear. Maybe just last one for me on your capital allocation priorities. You've obviously put forth a strong share repurchase authorization and have been aggressive with that so far. How should we think about how aggressive you expect to be on the repurchases, certainly as your shares further strengthen?
Yes. So from our perspective, the approach would be to maintain a more uniform cadence. And as you think about the $24 million number, not all of it this quarter falls under the program, right? If you think about the split of that $24 million because we made the announcement of our $75 million program in tandem with our Q4 earnings, that was middle of Feb. Only $15.3 million of these repurchases were made after the new program was announced. So from our perspective, we're trying to spread it out. We are not trying to front-load it. We are not trying to time the market or be selective. We want to be consistent. And I think that's the approach we'll take over the entire duration of the 12-month program.
Your last and final question comes from the line of Rohan Vasudeva with Baird.
I think most of my questions have been asked, so I'll keep this brief. But I just wanted to confirm that there was no ERC benefit to cost of sales in this quarter, correct?
That is correct. There were no ERC receipts and no ERC impact to our P&L and financial statements this quarter.
Okay. And then you briefly touched on it in the last question to keep a consistent cadence for repurchases. It looks like you'll run through your authorization or finish your authorization in about two quarters. Can we expect that you'll re-up your authorization after that? Or would you guys consider another way of returning capital to shareholders?
Yes. So Rohan, what we were doing, again, just going back to that $24 million number, as I said, $15 million and change, so to be precise, $15.3 million of those repurchases were made after the announcement of the new program in middle of Feb. So if you think about what we spent under the program, it's $15 million. You do an annualization of that, and it is under the $75 million number. The additional numbers within that $24 million were pertaining to the previous program and our regular open market repurchases. So yes, the number of $24 million seems elevated in that context. It's elevated in the context of our total repurchases last year being $61 million, but we are not trying to rush through the program by any stretch. From our perspective, we want to keep it uniform and present over the course of the year. Now if there are any reasons to accelerate down the road, we will be open to that, but that's not the intent and that's not how we will -- we've structured the program at this point of time. So we would rather be consistent than lumpy.
I will now turn the call back over to Ted Wahl for closing remarks.
Thank you. As we prepare for the remainder of 2026, our 50th anniversary, the company's underlying fundamentals are more robust than ever. Our leadership and management team, our enhanced value proposition, our business model and visibility we have into that business model, our training and learning platforms, our KPIs and key business trends and our strong balance sheet and ROIC profile. And with the industry at the beginning stages of a multi-decade demographic tailwind, we are incredibly well positioned to capitalize on the abundance of opportunities that lie ahead and deliver meaningful long-term shareholder value. So on behalf of Matt, Vikas and all of us at Healthcare Services Group, thank you, Rebecca, for hosting the call today, and thank you, everyone, for joining.
Ladies and gentlemen, that concludes today's call. Thank you all for joining. You may now disconnect.
Investor releaseQuarter not tagged2026-02-12Healthcare Services Group Inc (HCSG) Q4 2025 Earnings Call Highlights: Strong Revenue Growth ...
GuruFocus.com
Healthcare Services Group Inc (HCSG) Q4 2025 Earnings Call Highlights: Strong Revenue Growth ...
This article first appeared on GuruFocus. Revenue: $466.7 million, a 6.6% increase over the prior year. Environmental Services Revenue: $210.8 million with a margin of 12.6%. Dietary Services Revenue: $255.9 million with a margin of 7.2%. Cost of Services: $394.6 million or 84.6% of revenue. SG&A Expenses: $46.2 million, adjusted to $45.8 million or 9.8% of revenue. Net Income: $31.2 million. Diluted Earnings Per Share: $0.44 per share. Cash Flow from Operations: $17.4 million, adjusted to $36.4 million. Cash and Marketable Securities: $203.9 million. Share Repurchase Program: Completed $50 million plan; new $75 million plan authorized. Warning! GuruFocus has detected 6 Warning Signs with HCSG. Is HCSG fairly valued? Test your thesis with our free DCF calculator. Release Date: February 11, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Healthcare Services Group Inc (NASDAQ:HCSG) exceeded its initial 2025 expectations for revenue, earnings, and cash flow. The company achieved a significant milestone with its campus division reaching over $100 million in revenue. HCSG successfully managed cost of services and SG&A within targeted ranges, generating significant free cash flow. The company completed a $50 million share repurchase plan ahead of schedule and announced a new $75 million share repurchase plan for 2026. HCSG has a strong balance sheet and robust cash flow, with cash and marketable securities of $203.9 million and an undrawn $300 million credit facility. The transition to service day-based billing introduced a Q4 to Q1 revenue dynamic, impacting quarterly revenue comparisons. The effective tax rate for 2026 is expected to increase to approximately 25%, up from a 13% expense in 2025. The company's growth is limited by its ability to hire, develop, and retain management candidates. There is uncertainty regarding future Employee Retention Credit (ERC) receipts, which previously contributed to cash flow. The timing of new business adds can be fluid, potentially impacting quarterly revenue and growth expectations. Q: How are you thinking about the revenue upside opportunity given the strong fundamentals in the nursing home sector and growth opportunities in campus services? A: Theodore Wahl, President and CEO, explained that the company continues to execute its organic growth strategy by developing...
Investor releaseQuarter not tagged2026-02-12Healthcare Services Group, Inc. Q4 2025 Earnings Call Summary
Moby
Healthcare Services Group, Inc. Q4 2025 Earnings Call Summary
Performance exceeded 2025 expectations due to disciplined execution of strategic priorities, resulting in 7% year-over-year revenue growth. The Campus division reached a $100 million revenue milestone, validating the company's expansion into non-skilled nursing facility markets. Management attributes margin strength to high-level service execution, including systems adherence, budget discipline, and regulatory compliance. A multi-decade demographic tailwind is emerging as the first baby boomers turn 80 in 2026, increasing demand for long-term and post-acute care. Operational improvements in workers' compensation and general liability efficiencies contributed to managing cost of services within targeted ranges. The growth rate is primarily limited by the internal capacity to hire, develop, and retain management candidates rather than market demand. Management noted a stable reimbursement environment and increasing workforce availability as key positive industry operating trends. Management expects mid-single-digit revenue growth for 2026, driven by a robust sales pipeline and 90% plus facility retention rates. A new $75 million share repurchase plan was authorized for the next 12 months, reflecting confidence in valuation and cash flow generation. The 2026 financial framework targets cost of services at approximately 86% and SG&A between 9.5% and 10.5%. Revenue cadence for 2026 assumes a Q1 range of $460 million to $465 million with sequential growth expected in the second half of the year. The effective tax rate is projected to normalize to approximately 25% in 2026 following one-time ERC-related benefits in 2025. Systematic contract upgrades have shifted billings from fixed monthly fees to service-day-based models to improve pricing mechanics and cash flow. The shift to service-day billing introduced a Q4 to Q1 revenue dynamic where fewer days in Q1 can impact revenue by over $10 million. An $8.3 million tax benefit was recognized in Q4 related to the treatment of Employee Retention Credit (ERC) receipts. The company ended 2025 with $203.9 million in cash and an undrawn $300 million credit facility, providing significant liquidity for M&A and buybacks. Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Management clarified that growth is execution-based and...
Investor releaseQuarter not tagged2026-02-11Healthcare Services Group Q4 Earnings Call Highlights
MarketBeat
Healthcare Services Group Q4 Earnings Call Highlights
Healthcare Services Group closed fiscal 2025 ahead of expectations with more than 7% year‑over‑year revenue growth, Q4 revenue of $466.7 million, net income of $31.2 million (EPS $0.44), strong free cash flow, and its campus division surpassing $100 million in revenue. Management projects mid‑single‑digit revenue growth in 2026, with Q1 revenue guided to $460–$465 million and targets to manage cost of services around 86% and SG&A at 9.5–10.5%, while expecting an approximate 25% effective tax rate for 2026. The company has upgraded contracts (including service‑day billing) to improve margin visibility and collections, ended 2025 with $203.9 million in cash and an undrawn $300 million revolver, and completed a $50 million buyback early while planning $75 million in repurchases and board authorization to repurchase up to 10 million shares. Interested in Healthcare Services Group, Inc.? Here are five stocks we like better. Cigna Considers Humana Acquisition – What It Means for the Stocks Healthcare Services Group (NASDAQ:HCSG) executives said the company closed fiscal 2025 with results that exceeded its initial expectations for revenue, earnings, and cash flow, citing what management described as solid industry fundamentals and disciplined execution against strategic priorities. President and CEO Ted Wahl said the company delivered more than 7% year-over-year revenue growth in 2025 and generated “significant” free cash flow, while keeping cost of services and SG&A within targeted ranges. Wahl also pointed to the company’s campus division as a notable growth driver, saying it surpassed $100 million in revenue during the year. → Once Upon A Farm: Buy the $1B Growth Story? Is Cigna Group the Nation's Best-Run Health Insurance Company? Wahl characterized the long-term and post-acute care environment as supportive, pointing to demographic trends as a multi-decade tailwind. He noted that the first baby boomers will turn 80 in 2026 and said management expects demand for services in the sector to increase in coming years. He also cited steady occupancy, improving workforce availability, and a stable reimbursement environment as positive operating trends. Chief Communications Officer Matt McKee reported fourth-quarter revenue of $466.7 million, up 6.6% from the prior year. Segment results were: Environmental services: $210.8 million of revenue with a 12.6% segment margin...
TranscriptFY2025 Q42026-02-11FY2025 Q4 earnings call transcript
Earnings source - 24 paragraphs
FY2025 Q4 earnings call transcript
Thank you for standing by, and welcome to the Healthcare Services Group, Inc.'s Fourth Quarter 2025 Earnings Conference Call. The matters discussed on today's conference call include forward-looking statements about the business prospects of Healthcare Services Group Inc. For Healthcare Services Group, Inc.'s most recent forward-looking statement notice, please refer to the press release issued this morning, which can be found on our website, www.hcsg.com. Actual results may differ materially from those expressed or implied as a result of various risks, uncertainties and important factors, including those discussed in the risk factors, MD&A and other sections of the annual report on Form 10-K and Healthcare Services Group, Inc.'s other SEC filings and as indicated in our most recent forward-looking statements notice. Additionally, management will be discussing certain non-GAAP financial measures. A reconciliation of these items to U.S. GAAP can be found in this morning's press release. [Operator Instructions] I'd now like to turn the call over to Ted Wahl, President and CEO. You may begin.
Good morning, everyone, and welcome to HCSG's Fourth Quarter 2025 Earnings Call. With me today are Matt McKee, our Chief Communications Officer; and Vikas Singh, our Chief Financial Officer. Earlier this morning, we released our fourth quarter results and plan on filing our 10-K by the end of the week. Today, in my opening remarks, I'll discuss our 2025 highlights, share our perspective on the general business environment, discuss our strategic priorities for the year ahead and provide details on our new $75 million share repurchase plan. Matt will then provide a more detailed discussion on our Q4 results, and then Vikas will provide an update on our more recent contract enhancements, liquidity position and capital allocation progression. We will then open up the call for Q&A. So with that overview, I'd like to now discuss our 2025 highlights. I am extremely pleased with our fourth quarter performance, which capped a strong year for Healthcare Services Group. Against the backdrop of solid industry fundamentals, we exceeded our initial 2025 expectations for revenue, earnings and cash flow, driven by disciplined execution of our strategic priorities. Year-over-year revenue was up over 7% with our campus division reaching a significant milestone in its growth journey, achieving over $100 million in revenue. We successfully managed cost of services and SG&A within our targeted ranges, and we generated significant free cash flow. We also returned over $60 million of capital through our share repurchase program and ended the year with a strong balance sheet and ROIC profile, underscoring our focus on value-creating capital deployment. I'd like to now share our perspective on the general business environment. Industry fundamentals continue to gain strength, highlighted by the multi-decade demographic tailwind that is now beginning to work its way into the long-term and post-acute care system. In 2026, the first baby boomers will turn 80 years old. And by the year 2030, all 70 million-plus boomers will be over the age of 65, with the oldest being in their mid-80s, the primary age cohort for long-term and post-acute care utilization. We expect that the demand and opportunities for service providers in this space, especially for those with compelling value propositions, durable business models and market-leading positions to only increase in the months and years ahead. The most recent industry operating trends remain positive as well, highlighted by steady occupancy, increasing workforce availability and a stable reimbursement environment. We remain optimistic that the administration will continue to prioritize the rationalization of regulations and policy to better align with the changing and expanding needs of our nation's most vulnerable and the provider communities we service. Looking ahead to 2026, our top 3 strategic priorities remain: driving growth by developing management candidates, converting sales pipeline opportunities and retaining our existing facility business, managing cost through field-based operational execution and prudent spend management at the enterprise level and optimizing cash flow with increased customer payment frequency, enhanced contract terms and disciplined working capital management. We are optimistic about our trajectory and expect mid-single-digit revenue growth in the year ahead. We remain confident that continuing to execute on our strategic priorities, supported by our robust business fundamentals will enable us to drive growth, while delivering sustainable, profitable results. Finally, in conjunction with our earnings release, we announced the completion of our $50 million 12-month share repurchase plan, 5 months ahead of schedule. We also announced plans to further accelerate the pace of our share buybacks in 2026 and intend to repurchase $75 million of our common stock over the next 12 months. Over the past few years, we have continued to strengthen our balance sheet and expect strong cash flow generation over the next 12 months and beyond. We have demonstrated a prudent and balanced approach to capital allocation, including, first and foremost, investing in our growth initiatives. The current valuation of our shares relative to our long-term growth potential presents a compelling opportunity to return meaningful capital to shareholders through the buyback. So with those introductory comments, I'll turn the call over to Matt.
Thanks, Ted, and good morning, everyone. Revenue was reported at $466.7 million, a 6.6% increase over the prior year. Segment revenues and margins for Environmental Services were reported at $210.8 million and 12.6%. Segment revenues and margins for Dietary Services were reported at $255.9 million and 7.2%. As far as the cadence of our 2026 growth, while we don't provide full year revenue guidance broken out by quarter, our 2026 growth plans are oriented as follows: Q1 revenue in the $460 million to $465 million range with a step-up in Q2 revenue and then sequential revenue growth in the second half of the year compared to the first half of the year, culminating in mid-single-digit revenue growth for the full year 2026. Cost of services was recorded at $394.6 million or 84.6%. Cost of services benefited from strong service execution, workers' comp and general liability efficiencies and lower bad debt expense. Our 2026 goal is to manage the cost of services in the 86% range. SG&A was reported at $46.2 million, but after adjusting for the $0.4 million increase in deferred compensation, SG&A was $45.8 million or 9.8%. Our 2026 goal is to manage SG&A in the 9.5% to 10.5% range based on investments that we've made and spoken about in previous quarters with the longer-term goal of managing those costs into the 8.5% to 9.5% range. The effective tax rate for the fourth quarter was reported as a 9.4% benefit and the effective tax rate for the year was reported as a 13% expense. The effective tax rates include an $8.3 million or $0.12 per share benefit related to the treatment of certain ERC receipts recognized in the third quarter. The company, in consultation with third-party experts has determined its tax position with respect to these receipts. We expect our 2026 effective tax rate to be approximately 25%. Net income and diluted earnings per share were reported at $31.2 million and $0.44 per share. Net income and diluted earnings per share included an $8.3 million or $0.12 per share benefit related to the tax treatment of certain ERC receipts as previously mentioned. Cash flow from operations was reported at $17.4 million. After adjusting for the $19 million decrease in the payroll accrual, cash flow from operations was $36.4 million. I'd now like to turn the call over to Vikas.
Thank you, Matt, and good morning, everyone. Before reviewing our liquidity position and capital allocation priorities, I'll first highlight the favorable evolution of our contracts and the resulting impact on the business. Over the past few years, we have deliberately and systematically upgraded our contracts to improve both pricing mechanics and cash flow. These changes were designed to pass through cost increases with greater certainty and speed, increase payment frequency relative to monthly collections and shift from fixed monthly billings to billings based on the number of service days, the last being a particular area of focus over the past 12 months. As a result, we've seen several meaningful benefits, including improved margin visibility and stronger collection trends, which have contributed to lower days sales outstanding. One implication of the move to service day-based billing is that revenue is now more directly influenced by the number of days in a given quarter. While this has been largely beneficial, it has introduced a Q4 to Q1 dynamic that was not as pronounced historically. For example, Q4 2025 had 92 service days, while Q1 2026 has 90 days. Applied to our Q4 2025 revenue base, that difference would equate to more than $10 million. Our Q1 revenue range reflects performance above what the day count dynamic alone would imply. That's fueled by sustained momentum across the business. This outlook extends our pattern of consistent year-over-year quarterly growth and reinforces our conviction in delivering full year growth in the mid-single digits for 2026. The service day impact is not expected to be a factor in the remaining quarters of the year. Given the number of days per quarter are more evenly distributed, they're also balanced by offsetting events. So overall, while the Q4 to Q1 dynamic is a relatively recent result of contract changes that have been a strategic priority for us, we are very pleased with the overall impact these actions have had on the business and believe they position us well with a more durable and sustainable model going forward. Our primary sources of liquidity are cash flow from operating activities, cash and cash equivalents and our revolving credit facility. We wrapped up 2025 with cash and marketable securities of $203.9 million, and our credit facility of $300 million was undrawn with utilization limited to LCs only. This strong position was driven by top line growth combined with robust collections throughout the year that enabled us to reduce our receivable balance and bring down our DSOs. The increase in our cash position also reflects ERC receipts received during the year. However, we did not receive or recognize any ERC proceeds in the fourth quarter. Moreover, there can be no certainty regarding future receipts. On the capital allocation front, our 2026 priorities remain unchanged. We will continue to prioritize direct investments towards organic growth, strategic acquisitions and opportunistic share repurchases. As Ted referenced earlier, we completed our $50 million share repurchase program in January 2026, well ahead of the original 12-month time line. Those share repurchases included $19.6 million of buybacks during the fourth quarter, which contributed to our $61.6 million of share repurchases in 2025. Additionally, in February 2026, our Board of Directors authorized the repurchase of up to 10 million outstanding shares of common stock. Alongside that authorization, we announced plans to accelerate our share repurchase activity and expect to repurchase $75 million of our common stock over the next 12 months. With that, we will conclude our opening remarks and open up the call for Q&A.
[Operator Instructions] Your first question today comes from the line of A.J. Rice from UBS.
This is James on for A.J. Maybe if I could just start with how you guys are potentially thinking about the revenue upside opportunity. I know mid-single digits you've been talking about for a while for this year. But just given the strong underlying fundamentals of the nursing home sector plus the cross-sell opportunities and also the growth opportunity in campus, just wanted to get your thoughts there.
Sure, James. Overall, we continued to successfully execute on our organic growth strategy, largely by developing management candidates, converting sales pipeline opportunities and retaining our existing facility business. That's really our growth algorithm. Since we operate in a largely untapped market, where the demand for the services is greater than what we're capable of managing, our growth out is largely execution based. So we do, in many respects, retain control of that growth. Our pipeline is robust and growing. We have a highly structured sales process from prospecting all the way through closing and the demand for the services is as strong as ever. So for us, as we look out over the next 12 to 18 months, James, the growth rate limiting factor is really our ability to successfully hire, develop and retain the next generation of management candidates. More than any other factor, that's going to be the catalyst for us in sustaining the new business momentum we've seen over the past year or 2 as well as related to any potential upside opportunity.
Got it. That's helpful. Maybe just one more, if I could. It looked like margins in both segments had some nice expansion. Maybe just what are your thoughts on where those could end up in 2026?
Yes. James, you're right. Certainly, we saw a nice output in margins, and obviously, that was reflected in cost of services as well. And really, that comes down to what we've talked about consistently and previously, which is the primary driver being overall service execution and the recent positive service execution trends in customer experience, systems adherence, regulatory compliance, budget discipline, all of those are near-term margin drivers, and they carried into Q4, and the expectation is that they'll carry forward into 2026 as well. So that's why we're confident in our ability to continue managing cost of services in that 86% range. That said, there's always going to be month-to-month and quarter-to-quarter movement and the timing of certain items certainly had a positive impact on Q4 results in cost of services. And of course, that feeds through into the segment margins as well. You think about workers' comp and general liability efficiencies that continue to be driven by our focus and commitment to training and safety protocol that have been implemented out in the facilities, lower bad debt expense, which we've noted will likely be a bit inconsistent in the near term, but is favorably impacted by the strong cash collection efforts and the scarcity of customer bankruptcies and reorgs during the quarter. But ultimately, you bring it back and it's ultimately far outweighed by that operational execution and some of those other factors. So we've got a firm commitment to 86% as the right cost of service target. And as we mentioned, that will ultimately feed into the segment margins as well.
Your next question comes from the line of Sean Dodge from BMO Capital Markets.
Congratulations on the quarter and on the year. Ted, you mentioned campus Services reaching $100 million of revenue. How is that split between Environmental Services and the Meriwether Godsey side? And just how should we be thinking about -- you've been incubating this, you've gotten comfortable with it. Is there anything left to do there before you can really begin to accelerate and scale it? And I guess what's the time line around when we start to see campus services really become kind of a more meaningful factor in your growth?
It's split pretty evenly, Sean, between our CSG brand and the Meriwether Godsey brand you referenced. So we're pleased with that. It provides a strong platform for future growth. And the organic growth element is going to be critical for us. We continue to see accelerated organic growth in both of those brands. And with the concentration primarily in the Northeast, Southeast through the Mid-Atlantic and the beginning stages of a Midwest expansion, that will be, we anticipate, fueled over the next 12 to 18 months by very strategic, very intentional M&A to be able to land and expand. So to find those brands that we've talked about before that meet our criteria in a specific market, complement the growth strategy that we've laid out and then organically grow those brands with the support and the supplementation from the home office here. So we're very well positioned. That milestone is a critical milestone as we think about it, reinforces our conviction in the model and the niche we've carved out. So we're expecting continued accelerated growth in the year ahead. And then beyond, really the possibilities are very compelling and powerful.
Okay. And then on cash from operations, you had a great performance in 2025, even after you strip out the ERC payments. How should we be thinking about cash from ops trajectory for 2026? You said mid-single revenue growth, you gave some margin targets. You've talked before about cash from ops approximating net income. Is that still kind of the message, the expectation for 2026?
Yes, Sean, that's spot on. I think our expectation continues to be that net income is the best proxy for cash flow from operations, excluding the change in payroll accrual. And again, I think it goes back to the indication we are suggesting for the year to follow, which is mid-single-digit revenue growth, margins consistent with what we've said in the past, which is 86% cost of sales. 10% SG&A at the midpoint of our short-term target range and an effective tax rate of, give or take, 25%, which is what we've done historically and overall collections matching revenue. And that leads to an outcome, where net income will be the best proxy for what our cash flows will be going forward.
Okay. And then just last on the buyback, the plan to purchase or repurchase $75 million of stock over the next 12 months. Maybe just balancing that against the M&A opportunity, buying back that amount of stock, how much does that or how much room does that give you to still do M&A?
Yes. So Sean, what we've done over the last few quarters is prime our balance sheet for all our capital allocation priorities. So you would see in 2025, we've gone through the year without drawing on our line of credit. We've built up our cash balance, and now we are sitting at a balance of $200 million plus in terms of securities and cash, which is substantial. We have an undrawn line of credit. And as we think about all the priorities, focusing on organic growth, M&A, share buyback, we feel very comfortable with our liquidity position and feel confident and comfortable that we can go after all the 3 priorities without having to worry about liquidity. I think we've put our balance sheet in a spot where all those priorities can be moved forward without one compromising the other. Now that said, if we ever find ourselves in the happy spot of finding a substantial M&A, the line of credit gives us a lot of cushion. So long way of saying that we don't really see a conflict between the priorities and our liquidity.
Your next question comes from the line of Ryan Daniels from William Blair.
This is Matthew Mardula on for Ryan Daniels. And I know new business adds were a large part of the growth in 2025. But when thinking about the setup for this year, do you believe or maybe even anticipate an even larger amount of new businesses added throughout the year? And I know the timing of new businesses can vary between even months or quarters. But given the improvement in the industry and the potential of continuing, any color into how you are thinking about new business adds and the drivers of that throughout this year?
Sure, Matthew. We highlighted that in 2026, we're expecting mid-single-digit revenue growth along the lines of the cadence that Matt described in his opening remarks, and you referenced timing, but as always is the case, the timing of new business adds is a factor, and that can be fluid quarter-to-quarter, knowing there's always a subset of opportunities intra-quarter that could be pushed out or pulled forward. You think about the difference between starting a new opportunity on March 1 as opposed to April 1, maybe insignificant on a year-over-year basis, but that could be meaningful to a given quarter. Again, that's why our mid-single-digit guidance is really based off annual growth expectations, whereas our quarter-to-quarter estimates are ranges that are intended to provide that additional near-term visibility. So again, in terms of driving that organic growth, I referenced it earlier, but our growth algorithm is very straightforward. It's execution-based. And with the pipeline that we've built, which is robust and the retention trends that we're seeing in that 90% plus range, the key for us in driving organic growth is going to be executing on that management development strategy, hiring, developing, retaining and then making sure that there's balance throughout the organization. Each of those components I referenced is supported by best-in-class leadership, systems, procedures in each of the divisions as well as the service center providing administrative support here, but the execution is region by region, area by area. And we're more convinced than ever that the decentralized approach puts us in the best position to -- in a very bottoms-up type of way, deliver on that mid-single-digit growth expectation certainly over the next 12 months, but perhaps most importantly, over the next 3 to 5 years as we think about the longer-term outlook.
Got it. And then how have the services you have performed in the skilled nursing facilities compared to the other facilities you have performed at this year? Were just all types of facilities performing better than expectations? Or are there any certain ones performing better than others that need to call out from last year? And then also just kind of looking ahead to 2026, do you expect similar trends to persist or any changes in growth regarding facility types, especially with any color with the skilled nursing facilities?
Yes. I would say, Matthew, from the previous comments that I made with respect to the strong performance in cost of services and the impact that, that's had on gross margin, our service execution across really all service segments and customer types, inclusive of facility types remained remarkably consistent throughout the course of 2025. That's absolutely our expectation going forward in 2026 as well. We certainly don't take that for granted. There's a heck of a lot of effort that goes into implementing our systems and most importantly, adhering to our systems at the facility level to not only deliver relative to budget and to deliver the margin and cost of services that we're anticipating. But more importantly, to do so within a framework that allows for a high degree of operational execution, client satisfaction and all of those other really important elements that are critical to our success at the facility level. So really strong performance across all verticals and segments, and the expectation is absolutely that, that continues throughout the course of 2026 and beyond as well.
And we have reached the end of our question-and-answer session. I will now turn the call back over to Ted Wahl for closing remarks.
Okay. Great. Thank you, Rob. As we enter 2026, our 50th anniversary, the company's underlying fundamentals are more robust than ever. Our leadership and management team, our enhanced value proposition, our business model and the visibility we have into that model, our training and learning platforms, our KPIs and key business trends and our strong balance sheet. And with the industry at the beginning of a multi-decade demographic tailwind, we are incredibly well positioned to capitalize on the abundance of opportunities that lie ahead and deliver meaningful long-term shareholder value. So on behalf of Matt, Vikas and all of us at Healthcare Services Group, Rob, thank you for hosting the call today, and thank you again, everyone, for participating.
This concludes today's conference call. Thank you for your participation. You may now disconnect.
Investor releaseQuarter not tagged2026-01-03Pulling back 12% this week, Healthcare Services Group's NASDAQ:HCSG) one-year decline in earnings may be coming into investors focus
Simply Wall St.
Pulling back 12% this week, Healthcare Services Group's NASDAQ:HCSG) one-year decline in earnings may be coming into investors focus
Healthcare Services Group, Inc. (NASDAQ:HCSG) shareholders might be concerned after seeing the share price drop 12% in the last week. But that doesn't change the fact that the returns over the last year have been pleasing. To wit, it had solidly beat the market, up 48%. While this past week has detracted from the company's one-year return, let's look at the recent trends of the underlying business and see if the gains have been in alignment. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. During the last year, Healthcare Services Group actually saw its earnings per share drop 21%. Given the share price gain, we doubt the market is measuring progress with EPS. Indeed, when EPS is declining but the share price is up, it often means the market is considering other factors. We think that the revenue growth of 6.3% could have some investors interested. Many businesses do go through a phase where they have to forgo some profits to drive business development, and sometimes its for the best. The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail). If you are thinking of buying or selling Healthcare Services Group stock, you should check out this FREE detailed report on its balance sheet. It's good to see that Healthcare Services Group has rewarded shareholders with a total shareholder return of 48% in the last twelve months. There's no doubt those recent returns are much better than the TSR loss of 7% per year over five years. We generally put more weight on the long term performance over the short term, but the recent improvement could hint at a (positive) inflection point within the business. Before spending more time on Healthcare Services Group it might be wise to click here to see if insiders have been buying or selling shares. Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings. Please note, the market...

